Literature DB >> 6682170

2-Fluoroestradiol. Separation of estrogenicity from carcinogenicity.

J G Liehr.   

Abstract

Estrogenic and carcinogenic activity are shown to be separable properties. 2-Fluoroestradiol, a modified estrogen, did not induce renal clear-cell carcinoma in male Syrian hamsters despite its estrogenic potency, which is comparable to that of estradiol. 4-Fluoroestradiol, also a potent estrogen, did induce renal clear-cell carcinoma in this animal model, but more slowly than estradiol. 2,4-Dideuterioestradiol was found to be as estrogenic and also as carcinogenic as estradiol itself.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6682170

Source DB:  PubMed          Journal:  Mol Pharmacol        ISSN: 0026-895X            Impact factor:   4.436


  13 in total

1.  Proceedings of the British Pharmacological Society. 12-14 September 1990, Belfast.

Authors: 
Journal:  Br J Clin Pharmacol       Date:  1991-02       Impact factor: 4.335

2.  Chemical modification modulates estrogenic activity, oxidative reactivity, and metabolic stability in 4'F-DMA, a new benzothiophene selective estrogen receptor modulator.

Authors:  Hong Liu; Judy L Bolton; Gregory R J Thatcher
Journal:  Chem Res Toxicol       Date:  2006-06       Impact factor: 3.739

3.  Role of Estrogen in Androgen-Induced Prostate Carcinogenesis in NBL Rats.

Authors:  Nur Ozten; Katherine Vega; Joachim Liehr; Xi Huang; Lori Horton; Ercole L Cavalieri; Eleanor G Rogan; Maarten C Bosland
Journal:  Horm Cancer       Date:  2019-03-16       Impact factor: 3.869

Review 4.  Metabolism of stilbene estrogens and steroidal estrogens in relation to carcinogenicity.

Authors:  M Metzler
Journal:  Arch Toxicol       Date:  1984-07       Impact factor: 5.153

5.  Morphologic transformation of human breast epithelial cells MCF-10A: dependence on an oxidative microenvironment and estrogen/epidermal growth factor receptors.

Authors:  Rita Yusuf; Krystyna Frenkel
Journal:  Cancer Cell Int       Date:  2010-09-01       Impact factor: 5.722

6.  The metabolism of 17 alpha-ethinyloestradiol by human liver microsomes: formation of catechol and chemically reactive metabolites.

Authors:  H S Purba; J L Maggs; M L Orme; D J Back; B K Park
Journal:  Br J Clin Pharmacol       Date:  1987-04       Impact factor: 4.335

7.  2-Hydroxylation of ethinyloestradiol in relation to the oxidation of sparteine and antipyrine.

Authors:  D J Back; J L Maggs; H S Purba; S Newby; B K Park
Journal:  Br J Clin Pharmacol       Date:  1984-10       Impact factor: 4.335

8.  Structural modulation of oxidative metabolism in design of improved benzothiophene selective estrogen receptor modulators.

Authors:  Zhihui Qin; Irida Kastrati; Rezene T Ashgodom; Daniel D Lantvit; Cassia R Overk; Yongsoo Choi; Richard B van Breemen; Judy L Bolton; Gregory R J Thatcher
Journal:  Drug Metab Dispos       Date:  2008-10-20       Impact factor: 3.922

9.  Modulation of estrogen-induced carcinogenesis by chemical modifications.

Authors:  J G Liehr
Journal:  Arch Toxicol       Date:  1984-07       Impact factor: 5.153

10.  Critical role of oxidative stress in estrogen-induced carcinogenesis.

Authors:  Hari K Bhat; Gloria Calaf; Tom K Hei; Theresa Loya; Jaydutt V Vadgama
Journal:  Proc Natl Acad Sci U S A       Date:  2003-03-24       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.